At a glance
ClinicalIndex Comparison RecordN/ACompleted· 131 enrolled
Drug / intervention
No Intervention - Observational Studyother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Measuring Cortisol Levels in Persons With Parkinson's (PD)
In Brief
An observational study evaluating No Intervention - Observational Study for Parkinson Disease and Huntington Disease. Completed, enrolled 131 participants across 2 sites.
Detailed Summary
The objective of this study is to evaluate the cortisol awakening response with persons with Parkinsons Disease (PD), Huntingtons Disease (HD), and controls. These data are desired so experience can be gained with measuring stress levels subjectively and objectively in persons with PD, HD, and controls.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsParkinson Disease, Huntington Disease
CountriesUnited States
Timeline
N/ACompletedFinished
20162017201820192020202120222023202420252026
First PostedApr 2016
Enrollment StartJun 2016
Primary CompletionNov 2023
TodayJul 2026
First PostedApr 4, 2016
Enrollment StartJun 1, 2016
Primary CompletionNov 16, 2023
TodayJul 2, 2026
Enrollment to primary: 7.5 yearsPosted 10.2 years ago
Interventions
No Intervention - Observational Studyother
No Intervention - Observational Study